[HTML][HTML] C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion
S Zhang, W Peng, H Wang, X Xiang, L Ye… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Although immune checkpoint blockade (ICB) therapy has shown remarkable
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion
S Zhang, W Peng, H Wang, X Xiang… - Journal for …, 2023 - search.proquest.com
Background Although immune checkpoint blockade (ICB) therapy has shown remarkable
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion
S Zhang, W Peng, H Wang, X Xiang… - Journal for …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Although immune checkpoint blockade (ICB) therapy has shown remarkable
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
[HTML][HTML] C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion
S Zhang, W Peng, H Wang, X Xiang, L Ye… - … for ImmunoTherapy of …, 2023 - jitc.bmj.com
Background Although immune checkpoint blockade (ICB) therapy has shown remarkable
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion.
S Zhang, W Peng, H Wang, X Xiang, L Ye… - … for Immunotherapy of …, 2023 - europepmc.org
Background Although immune checkpoint blockade (ICB) therapy has shown remarkable
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
[引用][C] C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion
S Zhang, W Peng, H Wang, X Xiang, L Ye, X Wei… - europepmc.org
Background Although immune checkpoint blockade (ICB) therapy has shown remarkable
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …
benefits in cancers, a subset of patients with cancer exhibits unresponsiveness or develop …